Cutaneous Mastocytosis as a Rare Differential Diagnosis for Unilateral Chronic Facial Pain and Erythema: A Case Report

Cutaneous mastocytosis (CM) has been associated with urticaria, itching, and pain of the affected regions. Although the occurrence of CM in the facial skin is rare, it may be a cause of chronic facial pain, and pain characteristics may mistakenly be interpreted as trigeminal nerve pathology. However, the dermatological appearance of the different variants of cutaneous mastocytosis is distinct and should be considered as an uncommon differential diagnosis in an orofacial pain diagnostic algorithm. This article presents a case of telangiectasia macularis eruptiva perstans, a rare type of cutaneous mastocytosis, as the underlying cause of chronic facial pain, erythema, and swelling.

chronic facial pain; cutaneous mastocytosis; erythema; ketofifen; telangiectasia

1. rama Ta, corte-real i, Gomes PS, Escribano L, fernandes MH. Mastocytosis: Oral implications of a rare disease. J Oral Pathol Med 2011;40:441–450.

2. Bachmeyer c, Guillemette J, Blum L, et al. Telangiectasia macularis eruptiva perstans and multiple myeloma. J am acad Dermatol 2000;43:972–974.

3. Horny HP, Sotlar K, Valent P, Hartmann K. Mastocytosis: a disease of the hematopoietic stem cell. Dtsch arztebl int 2008;105:686–692.

4. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk res 2001;25:603–625.

5. Gibbs nf, friedlander Sf, Harpster Ef. Telangiectasia macularis eruptiva perstans. Pediatr Dermatol 2000;17:194–197.

6. cengizlier r, Hucumenoglu S, Ozen a, Tulin Sayli r. Treatment of telangiectasia macularis eruptiva perstans with montelukast. allergol immunopathol (Madr) 2009;37:334–336.

7. Betti r, Vergani r, Tolomio E, Martino P, crosti c. Guess what! Telangiectasia macularis eruptiva perstans involving the upper arms in an adult male. Eur J Dermatol 2000; 10: 563–564.

8. Gonzalez-castro U, Luelmo-aguilar J, castells-rodellas a. Unilateral facial telangiectasia macularis eruptiva perstans. int J Dermatol 1993;32:123–124.

9. fried SZ, Lynfield YL. Unilateral facial telangiectasia macularis eruptiva perstans. J am acad Dermatol 1987;16: 250–252.

10. Sarkany rP, Monk BE, Handfield-Jones SE. Telangiectasia macularis eruptiva perstans: a case report and review of the literature. clin Exp Dermatol 1998;23:38–39.

11. Martin LK, romanelli P, ahn YS, Kirsner rS. Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder. int J Dermatol 2004;43:922–924.

12. castling B, Smith aT, Myers B. involvement of the jaw bones in systemic mastocytosis. Br J Oral Maxillofac Surg 2006; 44:87–88.

13. rishpon a, Matz H, Gat a, Brenner S. Telangiectasia macularis eruptiva perstans: Unusual presentation and treatment. Skinmed 2006;5:300–302.

14. Tebbe B, Stavropoulos PG, Krasagakis K, Orfanos cE. cutaneous mastocytosis in adults. Evaluation of 14 patients with respect to systemic disease manifestations. Dermatology 1998;197:101–108.

15. Ellis DL. Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser. Dermatol Surg 1996;22:33–37.

16. Baron r, Binder a, Wasner G. neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet neurol 2010;9:807–819.

17. Horan rf, austen Kf. Systemic mastocytosis: retrospective review of a decade’s clinical experience at the Brigham and Women’s Hospital. J invest Dermatol 1991;96:5S–13S; discussion 14S, 60S–65S.

18. akoglu G, Erkin G, cakir B, et al. cutaneous mastocytosis: Demographic aspects and clinical features of 55 patients. J Eur acad Dermatol Venereol 2006;20:969–973.

19. Hoeger PH, Harper Ji. neonatal erythroderma: Differential diagnosis and management of the “red baby”. arch Dis child 1998;79:186–191.

20. izikson L, English Jc, 3rd, Zirwas MJ. The flushing patient: Differential diagnosis, workup, and treatment. J am acad Dermatol 2006;55:193–208.

21. Bulat V, Mihic LL, Situm M, Buljan M, Blajic i, Pusic J. Most common clinical presentations of cutaneous mastocytosis. acta clin croat 2009;48:59–64.

22. chodkiewicz HM, cohen Pr. Systemic mastocytosis- associated leonine facies and eyebrow loss. South Med J 2011; 104:236–238.

23. Barker a, Stewart rW. case report of mastocytosis in an adult. South Med J 2009;102:91–93.

24. Mutreja D, Purohit a, Singh PK, Pati HP. a 60-year-old lady with leonine facies: a rare diagnosis. indian J Pathol Microbiol 2012;55:566–568.

25. Horny HP, Sotlar K, Valent P. Mastocytosis: State of the art. Pathobiology 2007;74:121–132.

26. Hannaford r, rogers M. Presentation of cutaneous mastocytosis in 173 children. australas J Dermatol 2001;42:15–21.

27. Bloom B, Marchbein S, fischer M, Kamino H, Patel r, Lat-kowski Ja. Poikilodermatous mycosis fungoides. Dermatol Online J 2012;18:4.

28. Smith JH, Butterfield JH, Pardanani a, DeLuca Gc, cutrer fM. neurologic symptoms and diagnosis in adults with mast cell disease. clin neurol neurosurg 2011;113:570–574.

29. Smith JH, Butterfield JH, cutrer fM. Primary headache syndromes in systemic mastocytosis. cephalalgia 2011; 31: 1522–1531.

30. Dworkin rH, Backonja M, rowbotham Mc, et al. advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. arch neurol 2003;60:1524–1534.

31. Gruber r, Vassilaki i, Zelger B. concomitant juvenile xanthogranuloma and cutaneous mastocytosis in a 3-year-old Swedish girl: case report and review of the literature. int J Dermatol 2011;50:611–614.